Some rare disease collaborations have been described in the following publications:
Beaulieu CL, Samuels ME, Ekins S, McMaster CR, Edwards AM, Krainer AR, Hicks GG, Frey BJ, Boycott KM, Mackenzie AE, A generalizable pre-clinical research approach for orphan disease therapy, Orphanet 7:39, 2012
Wood J, Sames L, Moore A, Ekins S, The multifaceted roles of rare disease parent / patient advocates in drug discovery, Drug Disc Today, 18: 1043–1051, 2013.
Sames L, Moore, Arnold R and Ekins S, Recommendations to enable drug development for the inherited neuropathies: Charco-Marie-Tooth and Giant Axonal Neuropathy, F1000Research 3: 83, 2014
Litterman NK, Rhee, M, Swinney DC and Ekins S, Collaboration for rare disease drug discovery research, F1000Research 3:261, 2014
Ekins S, Collecting Rare Diseases, F1000Research, 3:260, 2014
Ekins S and Wood J, Incentives for starting small companies focused on rare and neglected diseases 33: 809-815, 2016
Other publications by our CEO can be found here